The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Open accessAbstract
Chemotherapy-induced cardiotoxicity is a serious complication that poses a serious threat to life and limits the clinical use of various chemotherapeutic agents, particularly the anthracyclines. Understanding molecular mechanisms of chemotherapy-induced cardiotoxicity is a key to effective preventive strategies and improved chemotherapy regimen. Although no reliable and effective preventive treatment has become available, numerous evidence demonstrates that chemotherapy-induced cardiotoxicity involves the generation of reactive oxygen species (ROS). This review provides an overview of the roles of oxidative stress in chemotherapy-induced cardiotoxicity using doxorubicin, which is one of the most effective chemotherapeutic agents against a wide range of cancers, as an example. Current understanding in the molecular mechanisms of ROS-mediated cardiotoxicity will be explored and discussed, with emphasis on cardiomyocyte apoptosis leading to cardiomyopathy. The review will conclude with perspectives on model development needed to facilitate further progress and understanding on chemotherapy-induced cardiotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Venkatakrishnan, C. D., Tewari, A. K., Moldovan, L., Cardounel, A. J., Zweier, J. L., Kuppusamy, P., & Ilangovan, G. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00395.2006 · Cited by 80
RetractedColowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Emerging roles of caspase-3 in apoptosis
Porter, A. G., & Jänicke, R. U. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400476 · Cited by 3,855
Doxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
Free radicals and antioxidants in human health: current status and future prospects.
Devasagayam, T. P. A., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S., & Lele, R. D. (2004) · PubMed · Cited by 1,575
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Dhanasekaran, D. N., & Reddy, E. P. (2008) · Oncogene · doi:10.1038/onc.2008.301 · Cited by 1,525
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS
Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,350
Activation of the Cardiac Calcium Release Channel (Ryanodine Receptor) by Poly-S-Nitrosylation
Xu, L., Eu, J. P., Meissner, G., & Stamler, J. S. (1998) · Science · doi:10.1126/science.279.5348.234 · Cited by 990
Control of mitochondrial apoptosis by the Bcl-2 family
Brunelle, J. K., & Letai, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.031682 · Cited by 929
Hypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Smith, L. A., Cornelius, V. R., Plummer, C. J., Levitt, G., Verrill, M., Canney, P., & Jones, A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-337 · Cited by 753
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites
Doroshow, J. H., Locker, G. Y., & Myers, C. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109642 · Cited by 702
Drug-induced oxidative stress and toxicity
Deavall, D. G., Martin, E. A., Horner, J. M., & Roberts, R. (2012) · Journal of Toxicology · doi:10.1155/2012/645460 · Cited by 689
Siwik, D. A., Pagano, P. J., & Colucci, W. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c53 · Cited by 674
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
Swain, S. M., Whaley, F. S., Gerber, M. C., Weisberg, S., York, M., Spicer, D., Jones, S. E., Wadler, S., Desai, A., Vogel, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1318 · Cited by 664
Interaction of reactive oxygen species with ion transport mechanisms
Kourie, J. I. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.1.c1 · Cited by 643
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
Doroshow, J. H. (1983) · PubMed · Cited by 629
Redox regulation of cardiac calcium channels and transporters
ZIMA, A., & BLATTER, L. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.019 · Cited by 592
Anthracycline cardiomyopathy monitored by morphologic changes.
Billingham, M. E., Mason, J. W., Bristow, M. R., & Daniels, J. R. (1978) · PubMed · Cited by 586
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
Gianni, L., Munzone, E., Capri, G., Fulfaro, F., Tarenzi, E., Villani, F., Spreafico, C., Laffranchi, A., Caraceni, A., & Martini, C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2688 · Cited by 553
Childs, A. C., Phaneuf, S., Dirks, A. J., Phillips, T., & Leeuwenburgh, C. (2002) · PubMed · Cited by 525
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure
Li, J.-M., Gall, N. P., Grieve, D. J., Chen, M., & Shah, A. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000032031.30374.32 · Cited by 516
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., & Namba, M. (1998) · Circulation · doi:10.1161/01.cir.98.8.794 · Cited by 510
Caspase-8 and Bid: Caught in the act between death receptors and mitochondria
Kantari, C., & Walczak, H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.026 · Cited by 502
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
Tebbi, C. K., London, W. B., Friedman, D., Villaluna, D., De Alarcon, P. A., Constine, L. S., Mendenhall, N. P., Sposto, R., Chauvenet, A., & Schwartz, C. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3879 · Cited by 493
NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
Bachur, N. R., Gordon, S. L., Gee, M. V., & Kon, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.2.954 · Cited by 489
Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., & Maeda, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102417200 · Cited by 468
Lipid peroxidation and tissue damage.
Mylonas, C. C., & Kouretas, D. (1999) · PubMed · Cited by 431
Suematsu, N., Tsutsui, H., Wen, J., Kang, D., Ikeuchi, M., Ide, T., Hayashidani, S., Shiomi, T., Kubota, T., Hamasaki, N., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055318.09997.1f · Cited by 427
Cardiolipin, the heart of mitochondrial metabolism
Houtkooper, R. H., & Vaz, F. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8030-5 · Cited by 413
Cardiotoxicity of cytotoxic drugs
Schimmel, K. J. M., Richel, D. J., van den Brink, R. B. A., & Guchelaar, H.-J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.003 · Cited by 391
Hershman, D. L., McBride, R. B., Eisenberger, A., Tsai, W. Y., Grann, V. R., & Jacobson, J. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1242 · Cited by 390
Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues
Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D. A., & St. Clair, D. K. (2007) · Molecular Interventions · doi:10.1124/mi.7.3.6 · Cited by 387
Mukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 376
Fas death receptor signalling: roles of Bid and XIAP
Kaufmann, T., Strasser, A., & Jost, P. J. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.121 · Cited by 373
Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003890200 · Cited by 372
Spinale, F. G., Coker, M. L., Thomas, C. V., Walker, J. D., Mukherjee, R., & Hebbar, L. (1998) · Circulation Research · doi:10.1161/01.res.82.4.482 · Cited by 372
Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin
Vásquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S. S., Pritchard, & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366
Hirotani, S., Otsu, K., Nishida, K., Higuchi, Y., Morita, T., Nakayama, H., Yamaguchi, O., Mano, T., Matsumura, Y., Ueno, H., et al. (2002) · Circulation · doi:10.1161/hc0402.102863 · Cited by 360
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.
Olson, R. D., Mushlin, P. S., Brenner, D. E., Fleischer, S., Cusack, B. J., Chang, B. K., & Boucek, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3585 · Cited by 357
Regulation of CD95/Fas signaling at the DISC
Lavrik, I. N., & Krammer, P. H. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.155 · Cited by 355
Pimentel, D. R., Amin, J. K., Xiao, L., Miller, T., Viereck, J., Oliver-Krasinski, J., Baliga, R., Wang, J., Siwik, D. A., Singh, K., et al. (2001) · Circulation Research · doi:10.1161/hh1701.096615 · Cited by 332
Evidence of a specific complex between adriamycin and negatively-charged phospholipids
Goormaghtigh, E., Chatelain, P., Caspers, J., & Ruysschaert, J. M. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90145-5 · Cited by 310
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I
Wang, L., Ma, W., Markovich, R., Chen, J.-W., & Wang, P. H. (1998) · Circulation Research · doi:10.1161/01.res.83.5.516 · Cited by 287
TNFR1‐induced activation of the classical NF‐κB pathway
Wajant, H., & Scheurich, P. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08015.x · Cited by 285
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Kobayashi, S., Volden, P., Timm, D., Mao, K., Xu, X., & Liang, Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070037 · Cited by 284
Kwon, S. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00084-1 · Cited by 283
Siwik, D. A., Tzortzis, J. D., Pimental, D. R., Chang, D. L.-F., Pagano, P. J., Singh, K., Sawyer, D. B., & Colucci, W. S. (1999) · Circulation Research · doi:10.1161/01.res.85.2.147 · Cited by 277
Berlin, V., & Haseltine, W. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69315-4 · Cited by 275
Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
Sawyer, D. B., Peng, X., Chen, B., Pentassuglia, L., & Lim, C. C. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.06.007 · Cited by 270
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Gabizón, A. (2001) · PubMed · Cited by 259
Reactive oxygen species and oxidative DNA damage.
Hemnani, T., & Parihar, M. S. (1998) · PubMed · Cited by 255
Ito, H., Miller, S. C., Billingham, M. E., Akimoto, H., Torti, S. V., Wade, R., Gahlmann, R., Lyons, G., Kedes, L., & Torti, F. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4275 · Cited by 255
The Taxoids: Comparative Clinical Pharmacology and Therapeutic Potential
Eisenhauer, E. A., & Vermorken, J. B. (1998) · Drugs · doi:10.2165/00003495-199855010-00002 · Cited by 248
Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A. P., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 244
Sabri, A., Hughie, H. H., & Lucchesi, P. A. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770380034 · Cited by 236
Weinstein, D. M., Mihm, M. J., & Bauer, J. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39082-2 · Cited by 229
Izumiya, Y., Kim, S., Izumi, Y., Yoshida, K., Yoshiyama, M., Matsuzawa, A., Ichijo, H., & Iwao, H. (2003) · Circulation Research · doi:10.1161/01.res.0000100665.67510.f5 · Cited by 229
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
MINOTTI, G., CAIRO, G., & MONTI, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.199 · Cited by 214
LIPID PEROXIDATION AND ANTIOXIDANT ENZYMES IN ISOPROTERENOL INDUCED OXIDATIVE STRESS IN RAT TISSUES
RATHORE, N., JOHN, S., KALE, M., & BHATNAGAR, D. (1998) · Pharmacological Research · doi:10.1006/phrs.1998.0365 · Cited by 211
Mitochondrial defects in cardiomyopathy and neuromuscular disease
Wallace, D. C. (2000) · American Heart Journal · doi:10.1067/mhj.2000.103934 · Cited by 208
Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question
Van Herreweghe, F., Festjens, N., Declercq, W., & Vandenabeele, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0283-0 · Cited by 205
Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., & Cairo, G. (2001) · PubMed · Cited by 200
Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., Matsumura, Y., Ueno, H., Tada, M., & Hori, M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1505 · Cited by 192
Ueno, M., Kakinuma, Y., Yuhki, K.-I., Murakoshi, N., Iemitsu, M., Miyauchi, T., & Yamaguchi, I. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050980 · Cited by 189
Arai, M., Yoguchi, A., Takizawa, T., Yokoyama, T., Kanda, T., Kurabayashi, M., & Nagai, R. (2000) · Circulation Research · doi:10.1161/01.res.86.1.8 · Cited by 189
Kim, Y., Ma, A.-G., Kitta, K., Fitch, S. N., Ikeda, T., Ihara, Y., Simon, A. R., Evans, T., & Suzuki, Y. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.368 · Cited by 188
SPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.009 · Cited by 182
Lu, L., Wu, W., Yan, J., Li, X., Yu, H., & Yu, X. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.043 · Cited by 175
Minotti, G., Recalcati, S., Mordente, A., Liberi, G., Calafiore, A. M., Mancuso, C., Preziosi, P., & Cairo, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.7.541 · Cited by 173
Boucek, R. J., Olson, R. D., Brenner, D. E., Ogunbunmi, E. M., Inui, M., & Fleischer, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47666-1 · Cited by 172
Kawaguchi, T., Takemura, G., Kanamori, H., Takeyama, T., Watanabe, T., Morishita, K., Ogino, A., Tsujimoto, A., Goto, K., Maruyama, R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs282 · Cited by 172
Miranda, C. J., Makui, H., Soares, R. J., Bilodeau, M., Mui, J., Vali, H., Bertrand, R., Andrews, N. C., & Santos, M. M. (2003) · Blood · doi:10.1182/blood-2003-03-0869 · Cited by 168
Activation of Matrix Metalloproteinases in the Failing Human Heart: Breaking the Tie That Binds
Mann, D. L., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.98.17.1699 · Cited by 164
Panis, C., Herrera, A. C. S. A., Victorino, V. J., Campos, F. C., Freitas, L. F., De Rossi, T., Colado Simão, A. N., Cecchini, A. L., & Cecchini, R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1693-x · Cited by 164
Serrano, J., Palmeira, C. M., Kuehl, D. W., & Wallace, K. B. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00011-0 · Cited by 159
Date, M., Morita, T., Yamashita, N., Nishida, K., Yamaguchi, O., Higuchi, Y., Hirotani, S., Matsumura, Y., Hori, M., Tada, M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01826-5 · Cited by 158
Ghosh, J., Das, J., Manna, P., & Sil, P. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.048 · Cited by 155
Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
Sishi, B., Loos, B., van Rooyen, J., & Engelbrecht, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.005 · Cited by 153
Xu, X., Chen, K., Kobayashi, S., Timm, D. J., & Liang, Q. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189589 · Cited by 151
Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
Olson, R. D., MacDonald, J. S., VanBoxtel, C. J., Boerth, R. C., Harbison, R. D., Slonim, A. E., Freeman, R. W., & Oates, J. A. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32319-0 · Cited by 147
Kaplán, P., Babusikova, E., Lehotský, J., & Dobrota, D. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024145212616 · Cited by 138
Minotti, G., Recalcati, S., Menna, P., Salvatorelli, E., Corna, G., & Cairo, G. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)78025-8 · Cited by 137
Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
Pereira, G. C., Silva, A. M., Diogo, C. V., Carvalho, F. S., Monteiro, P. F., & Oliveira, P. J. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904812 · Cited by 136
Molecular Mechanisms of Doxorubicin-induced Cardiomyopathy
Jeyaseelan, R., Poizat, C. I., Wu, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5828 · Cited by 131
Sun, X., Zhou, Z., & Kang, Y. J. (2001) · PubMed · Cited by 130
Nitobe, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00646-6 · Cited by 126
Caroni, P., Villani, F., & Carafoli, E. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)81115-5 · Cited by 123
Matrix elasticity regulates the optimal cardiac myocyte shape for contractility
McCain, M. L., Yuan, H., Pasqualini, F. S., Campbell, P. H., & Parker, K. K. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2013 · Cited by 117
Parker, M. A., King, V., & Howard, K. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00371-6 · Cited by 107
Singal, P. K., & Pierce, G. N. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.3.h419 · Cited by 105
Regulation of Cardiolipin Biosynthesis in H9c2 Cardiac Myoblasts by Cytidine 5′-Triphosphate
Hatch, G. M., & McClarty, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.25810 · Cited by 90
A Comparative Study of Doxorubicin and Epirubicin in Patients with Metastatic Breast Cancer
Hortobágyi, G. N., Yap, H. Y., Kau, S., Fraschini, G., Ewer, M. S., Chawla, S. P., & Benjamin, R. S. (1989) · American Journal of Clinical Oncology · doi:10.1097/00000421-198902000-00014 · Cited by 88
Zhang, Y., Meng, C., Zhang, X.-M., Yuan, C., Wen, M.-D., Chen, Z., Dong, D., Gao, Y., Liu, C., & Zhang, Z. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219261 · Cited by 87
Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues.
Stewart, D. J., Grewaal, D. S., Green, R. M., Mikhael, N. Z., Goel, R., Montpetit, V., & Redmond, M. D. (1994) · PubMed · Cited by 87
Keung, E. C., Toll, L., Ellis, M., & Jensen, R. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115241 · Cited by 86
Smuder, A. J., Kavazis, A. N., Min, K., & Powers, S. K. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00924.2012 · Cited by 85
Dimitrakis, P., Romay-Ogando, M.-I., Timolati, F., Suter, T. M., & Zuppinger, C. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1475-8 · Cited by 82
Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestine
Odom, A., Hatwig, C. A., Stanley, J. S., & Benson, A. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90250-m · Cited by 76
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity
Bai, P., Mabley, J. G., Liaudet, L., Virág, L., Szabó, C., & Pacher, P. (2004) · Oncology Reports · doi:10.3892/or.11.2.505 · Cited by 74
Pathogenesis and prevention of doxorubicin cardiomyopathy.
Ferrans, V. J., Clark, J., Zhang, J., Yu, Z., & Herman, E. (1997) · PubMed · Cited by 68
Minotti, G., Mancuso, C., Frustaci, A., Mordente, A., Santini, S. A., Calafiore, A. M., Liberi, G., & Gentiloni, N. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118836 · Cited by 66
Ivanová, M., Dovinová, I., Okruhlicová, Ľ., Tribulová, N., Šimončíková, P., Barteková, M., Vlkovičová, J., & Barančík, M. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.194 · Cited by 63
Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes
Karagiannis, T. C., Lin, A. J., Ververis, K., Chang, L., Tang, M. M., Okabe, J., & El‐Osta, A. (2010) · Aging · doi:10.18632/aging.100203 · Cited by 55
Kizaki, K., Itô, R., Okada, M., Yoshioka, K., Uchide, T., Temma, K., MUTOH, K.-I., Uechi, M., & Hara, Y. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.01.001 · Cited by 50
Abdelgawad, H. M., & El‐Sawalhi, M. M. (2004) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20013 · Cited by 47
The role of frataxin in doxorubicin-mediated cardiac hypertrophy
Mouli, S., Nanayakkara, G., AlAlasmari, A., Eldoumani, H., Fu, X., Berlin, A., Lohani, M., Nie, B., Arnold, R. D., Kavazis, A. N., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00182.2015 · Cited by 45
Goetzenich, A., Hatam, N., Zernecke, A., Weber, C., Czarnotta, T., Autschbach, R., & Christiansen, S. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.06.025 · Cited by 43
Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats
Liu, B., Li, H., Qu, H., & Sun, B. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.759 · Cited by 40
Anthracycline-Dependent Cardiotoxicity and Extracellular Matrix Remodeling
Nikitovic, D., Juránek, I., Wilks, M. F., Tzardi, M. N., Tsatsakis, A. M., & Tzanakakis, G. N. (2014) · CHEST Journal · doi:10.1378/chest.14-0460 · Cited by 39
Nakamura, Y., Kanemaru, K., Kojima, R., Hashimoto, Y., Marunouchi, T., Oka, N., Ogura, T., Tanonaka, K., & Fukami, K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.181 · Cited by 31
Lien, Y., Noel, T. J., Liu, H., Stromberg, A. J., Chen, K.-C., & Clair, D. K. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3424 · Cited by 24
Spreeuwel, V. A. A., Bax, N. A. M., & Bouten, C. V. C. (2014) · OA Tissue Engineering · Cited by 12
Direct detection of paramagnetic species in adriamycin perfused rat hearts
Costa, L. E., Malatesta, V., Morazzoni, F., Scotti, R., Monti, E., & Paracchini, L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81218-x · Cited by 11
Cited by
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
D’Oria, R., Schipani, R., Leonardini, A., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5732956 · Cited by 376
Cappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Koleini, N., & Kardami, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16944 · Cited by 301
Reactive Oxygen Species‐Mediated Mechanisms of Action of Targeted Cancer Therapy
Teppo, H.-R., Soini, Y., & Karihtala, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1485283 · Cited by 162
Metadata
- Authors
- Angsutararux, P., Luanpitpong, S., & Issaragrisil, S.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2125304966
- Cited by
- 288
- References
- 124
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.